CULT+MATH · Ipalibo Da-Wariboko
Strategic Brief · V2
April 2026 · Confidential
Uniwyze — Website Strategy
The COA data
standard is here.
Your website
hasn't caught up.
Nkem, the March 31 DSHS rules went into effect seventeen days ago. Every licensed manufacturer in Texas now has a legal obligation to produce and electronically submit batch-specific COAs — the exact data infrastructure Uniwyze was built to ingest, classify, and surface to regulators. The regulatory window you've been building toward just opened. This brief is my read on what needs to change on the website before you walk through it.
You testified before DSHS on the proposed rules. Those rules are now law. Texas manufacturers must now produce batch-specific COAs, make them electronically available to DSHS on request, disclose standardized cannabinoid composition, and include a URL linking directly to lab data on every product label. This is not a future regulatory trend — it is a present mandate that went into effect three weeks ago.
And by November 2026, H.R. 5371 rewrites the federal definition of hemp to include total THC. Every state in the country will be navigating what Texas is navigating right now. The window is not just open in Texas — it's opening everywhere.
Texas DSHS rules live
Mar 31
Batch COAs now legally required. Electronically available to DSHS on request. Mandatory URL to lab data on every label.
Federal deadline
Nov '26
H.R. 5371 rewrites federal hemp definition nationwide. The Texas problem becomes every state's problem.
The market no competitor is serving
METRC, BioTrackTHC, ComplianceQuest — every major compliance platform helps operators avoid violations. None of them help regulators find them. That lane is unoccupied. That is Uniwyze's lane.
Texas market scale
$5.5B in annual hemp-derived sales · 6,000–7,000 registered retail outlets · $250M+ state tax revenue — all requiring compliance oversight that paper-based inspection cannot scale to.
The strategic opportunity
"Every competitor helps operators avoid violations. Uniwyze helps regulators find them. That is a fundamentally different product — and the category is genuinely unoccupied. The website needs to say that in the first ten seconds."
This is the most important thing I can show you. You have earned significant institutional credibility. A state regulator visiting your site today sees almost none of it. Every item below is traceable — either to your white paper, your regulatory brief, your LinkedIn, or the live site audit.
DSHS testimony
You were in the room where the rules were written. No competitor can say that. It is the single most powerful credibility signal a GovTech vendor can have — and it belongs in your hero section, not nowhere.
Not visible
U.S. Patent 18/124,443
Issued March 25, 2025
A legally protected taxonomy means the classification framework is scientifically defensible and institutionally permanent. Government buyers need to know the platform they adopt won't disappear or be copied.
Footer only
International implementation
Your white paper references successful deployment in multiple international jurisdictions. This signals production-readiness — not a pilot concept, a platform that has been used at scale.
Not visible
Pharmacological basis
Classification grounded in dose-response pharmacology, not marketing language. A regulator defending adoption internally needs this scientific foundation. Currently only in the white paper.
White paper only
Pilot framework
A structured, low-risk pilot pathway already exists in your regulatory brief. Government buyers need a defined, low-commitment entry point. You have one. It is not on the site.
Not visible
One thing to remove before anything else
"We're still building! This is our beta release." — This appears on your subscription page. A state agency evaluating compliance infrastructure cannot procure beta software. This single line is the most damaging thing on the current site for your primary audience. It comes down before the redesign begins.
The first ten seconds must do one job: a state cannabis regulator lands on the page and immediately understands that Uniwyze was built for the problem they are trying to solve right now. Not for dispensary shoppers. Not for consumers on a cannabis journey. For them.
The navigation must have a door for them. The current site has no government entry point anywhere — not in the nav, not in the adopters section, not in the CTAs. The new navigation should lead with: For Regulators · For Laboratories · For Operators · The Science · Request a Briefing.
The primary call to action must match how government buys. State agencies do not subscribe to beta software. They evaluate, pilot, and procure. The primary CTA is not "Try Uniwyze" — it is "Request a Pilot Briefing." One form. Agency name, state, contact. That's it.
The consumer layer stays — but moves downstream. The Entourage Score and visual wheel are genuinely distinctive. They do not disappear. They are repositioned as the downstream consumer output of a regulatory platform — not the product itself. Regulatory infrastructure first. Consumer application second.
The language shifts from "journey" to "oversight." Government buyers speak in oversight efficiency, enforcement accuracy, public safety, and taxpayer accountability. Every word on the government-facing pages passes through that filter.
Each concept makes a different bet about what a state regulator should feel when they encounter Uniwyze. These are not color palette variations — they are three different strategic positions. Your ranking tells me more than any question I can ask.
Direction A
The Standard
Uniwyze is the emerging standard for cannabis product intelligence — the way METRC became the standard for inventory tracking. The site feels like infrastructure. Authoritative, institutional, inevitable.
"What if Uniwyze felt as permanent and necessary as the regulations themselves?"
Direction B
The Scientist
Uniwyze leads with the pharmacological depth and scientific rigor behind the patent. Precise, evidence-based, trusted by people who read the data behind the data. The site feels like peer-reviewed infrastructure.
"What if Uniwyze felt like the most credible scientific voice in the room — the one regulators cite, not just use?"
Direction C
The Witness
Uniwyze leads with its presence in the regulatory process itself — the DSHS testimony, the rulemaking engagement, the direct relationship with the agencies it serves. The site feels like a partner already in the room.
"What if Uniwyze felt less like a product to procure and more like a collaborator already trusted by the agencies it serves?"
What I need from you
Tell me which direction — A, B, or C — feels closest to how you want Uniwyze to be encountered. That answer is where we start building.
You don't have to choose one cleanly. If A's authority and C's relationship feel right together, tell me that. If none of them are quite it, tell me what's missing. Your instinct in the next five minutes is worth more than another round of research.